These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37591615)

  • 21. Characterization of bone marrow heterogeneity in NK-AML (M4/M5) based on single-cell RNA sequencing.
    Wu W; Shi Z; Tang Z; Li H; Huang X; Liang X; Li J; Yao Y; Zhao W; Wu M; Luo J; Liu Z
    Exp Hematol Oncol; 2023 Mar; 12(1):25. PubMed ID: 36879313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia.
    Tang L; Wu J; Li CG; Jiang HW; Xu M; Du M; Yin Z; Mei H; Hu Y
    Clin Cancer Res; 2020 Apr; 26(7):1763-1772. PubMed ID: 31911547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD38 marks the exhausted CD8
    Reolo MJY; Otsuka M; Seow JJW; Lee J; Lee YH; Nguyen PHD; Lim CJ; Wasser M; Chua C; Lim TKH; Leow WQ; Chung A; Goh BKP; Chow PKH; DasGupta R; Yeong JPS; Chew V
    Front Immunol; 2023; 14():1182016. PubMed ID: 37377962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.
    Cianga VA; Campos Catafal L; Cianga P; Pavel Tanasa M; Cherry M; Collet P; Tavernier E; Guyotat D; Rusu C; Aanei CM
    Front Immunol; 2021; 12():665541. PubMed ID: 33986753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing.
    Zhou J; Chng WJ
    Front Oncol; 2024; 14():1365330. PubMed ID: 38711849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT
    Zeng X; Yao D; Liu L; Zhang Y; Lai J; Zhong J; Zha X; Lu Y; Jin Z; Chen S; Li Y; Xu L
    Asia Pac J Clin Oncol; 2022 Aug; 18(4):456-464. PubMed ID: 34811925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with
    Tan J; Chen S; Lu Y; Yao D; Xu L; Zhang Y; Yang L; Chen J; Lai J; Yu Z; Zhu K; Li Y
    Chin J Cancer Res; 2017 Oct; 29(5):463-470. PubMed ID: 29142466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
    Ferraro F; Miller CA; Christensen KA; Helton NM; O'Laughlin M; Fronick CC; Fulton RS; Kohlschmidt J; Eisfeld AK; Bloomfield CD; Ramakrishnan SM; Day RB; Wartman LD; Uy GL; Welch JS; Christopher MJ; Heath SE; Baty JD; Schuelke MJ; Payton JE; Spencer DH; Rettig MP; Link DC; Walter MJ; Westervelt P; DiPersio JF; Ley TJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML.
    Tan J; Yu Z; Huang J; Chen Y; Huang S; Yao D; Xu L; Lu Y; Chen S; Li Y
    Biomark Res; 2020; 8():6. PubMed ID: 32082573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional exhaustion of CD4
    Ozkazanc D; Yoyen-Ermis D; Tavukcuoglu E; Buyukasik Y; Esendagli G
    Immunology; 2016 Dec; 149(4):460-471. PubMed ID: 27565576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8
    Romine KA; MacPherson K; Cho HJ; Kosaka Y; Flynn PA; Byrd KH; Coy JL; Newman MT; Pandita R; Loo CP; Scott J; Adey AC; Lind EF
    Leukemia; 2023 Mar; 37(3):580-592. PubMed ID: 36681742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
    Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
    J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of T Cell Exhaustion by the First Donor Lymphocyte Infusion Is Associated with the Persistently Effective Antileukemic Responses in Patients with Relapsed AML after Allo-HSCT.
    Liu L; Chang YJ; Xu LP; Zhang XH; Wang Y; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1350-1359. PubMed ID: 29649617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
    Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
    Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia.
    Su X; Ma G; Bai X; Zhang J; Li M; Zhang F; Sun T; Ma D; Lu F; Ji C
    Front Cell Dev Biol; 2022; 10():978786. PubMed ID: 36313565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48.
    Zhang T; Fang Q; Liu P; Wang P; Feng C; Wang J
    J Transl Med; 2022 Sep; 20(1):394. PubMed ID: 36058936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.
    Fu D; Zhang B; Wu S; Feng J; Jiang H
    Front Cell Dev Biol; 2023; 11():1207642. PubMed ID: 37691822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.
    Kaweme NM; Zhou F
    Front Immunol; 2021; 12():683381. PubMed ID: 34220833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironment.
    Zhang H; Huang H; Wu S; He X; Chen J; Zheng X; Chen L; Wang Z
    Med Oncol; 2023 Aug; 40(10):285. PubMed ID: 37653265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia.
    Bou-Tayeh B; Laletin V; Salem N; Just-Landi S; Fares J; Leblanc R; Balzano M; Kerdiles YM; Bidaut G; Hérault O; Olive D; Aurrand-Lions M; Walzer T; Nunès JA; Fauriat C
    Front Immunol; 2021; 12():730970. PubMed ID: 34975835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.